These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 11896280)
1. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Wang JW; Howson JM; Ghansah T; Desponts C; Ninos JM; May SL; Nguyen KH; Toyama-Sorimachi N; Kerr WG Science; 2002 Mar; 295(5562):2094-7. PubMed ID: 11896280 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959 [TBL] [Abstract][Full Text] [Related]
3. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920 [TBL] [Abstract][Full Text] [Related]
4. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras. Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275 [TBL] [Abstract][Full Text] [Related]
5. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants. Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626 [TBL] [Abstract][Full Text] [Related]
6. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. Held W; Cado D; Raulet DH J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892 [TBL] [Abstract][Full Text] [Related]
7. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands. Naper C; Hayashi S; Kveberg L; Niemi EC; Lanier LL; Vaage JT; Ryan JC J Immunol; 2002 Jul; 169(1):22-30. PubMed ID: 12077224 [TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts. Raziuddin A; Bennett M; Winkler-Pickett R; Ortaldo JR; Longo DL; Murphy WJ Blood; 2000 Jun; 95(12):3840-4. PubMed ID: 10845918 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes. Iizuka K; Scalzo AA; Xian H; Yokoyama WM J Immunol; 2008 Mar; 180(5):3260-7. PubMed ID: 18292550 [TBL] [Abstract][Full Text] [Related]
10. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice. Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767 [TBL] [Abstract][Full Text] [Related]
11. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. Lowin-Kropf B; Kunz B; Beermann F; Held W J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732 [TBL] [Abstract][Full Text] [Related]
12. NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism. Hamby K; Trexler A; Pearson TC; Larsen CP; Rigby MR; Kean LS Am J Transplant; 2007 Aug; 7(8):1884-96. PubMed ID: 17617852 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631 [TBL] [Abstract][Full Text] [Related]
14. SHIP1 intrinsically regulates NK cell signaling and education, resulting in tolerance of an MHC class I-mismatched bone marrow graft in mice. Gumbleton M; Vivier E; Kerr WG J Immunol; 2015 Mar; 194(6):2847-54. PubMed ID: 25687756 [TBL] [Abstract][Full Text] [Related]
15. Altered expression of Ly-49 receptors on NK cells developing in mixed allogeneic bone marrow chimeras. Manilay JO; Waneck GL; Sykes M Int Immunol; 1998 Dec; 10(12):1943-55. PubMed ID: 9885916 [TBL] [Abstract][Full Text] [Related]
16. SHIP influences signals from CD48 and MHC class I ligands that regulate NK cell homeostasis, effector function, and repertoire formation. Fortenbery NR; Paraiso KH; Taniguchi M; Brooks C; Ibrahim L; Kerr WG J Immunol; 2010 May; 184(9):5065-74. PubMed ID: 20363967 [TBL] [Abstract][Full Text] [Related]
17. Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets. Wahle JA; Paraiso KH; Costello AL; Goll EL; Sentman CL; Kerr WG J Immunol; 2006 Jun; 176(12):7165-9. PubMed ID: 16751359 [TBL] [Abstract][Full Text] [Related]
18. NK cell tolerance in mixed allogeneic chimeras. Zhao Y; Ohdan H; Manilay JO; Sykes M J Immunol; 2003 Jun; 170(11):5398-405. PubMed ID: 12759414 [TBL] [Abstract][Full Text] [Related]
19. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens. Raziuddin A; Longo DL; Bennett M; Winkler-Pickett R; Ortaldo JR; Murphy WJ Blood; 2002 Oct; 100(8):3026-33. PubMed ID: 12351417 [TBL] [Abstract][Full Text] [Related]
20. Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Murphy WJ; Koh CY; Raziuddin A; Bennett M; Longo DL Immunol Rev; 2001 Jun; 181():279-89. PubMed ID: 11513149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]